This website is designed to support you, and your carers, with your treatment and is not a substitute for the Patient Information Leaflet (PIL) and User Manual that came with your medication and pen.

You have been diagnosed with osteoporosis which puts you at higher risk of fractures – partial or complete bone breaks. Fractures (broken bones) are most common in the hips, wrists and spine however, they can occur in other parts of the body. So it’s important to stay on your treatment.
More information about Osteoporosis can be found on the Royal Osteoporosis society website.
Movymia® (teriparatide) is a parathyroid treatment and helps increase bone formation. It works in a similar way to a naturally occurring hormone in your body, called parathyroid hormone, which helps build new bone.
It is self-administered as a quick once daily injection using a small, fine needle. Taking it daily and for as long as prescribed will help your bones to become stronger.
The information on this site is suitable for and solely intended for UK patients who have been prescribed Movymia following consultation with a UK healthcare professional. Are you a patient who has been prescribed this medicine by a UK healthcare professional?
UK-MOVY-51 | May 2025
The website you are going to is maintained by a third party over whom Thornton & Ross Limited has no control or responsibility. We have provided this link as an appropriate resource to our visitors but Thornton & Ross Limited is not responsible for the content or information on this site.